
Gabakan 300mg/500mcg Tablet
Marketer
Fortune Life Sciences Private Limited
Salt Composition
Gabapentin (300mg) + Methylcobalamin (500mcg)
Overview Gabakan 300mg/500mcg Tablet
Neuropathic pain is treated with the combined medication Gabakan 300mg/500mcg tablets, which regulate nerve cell calcium channel activity to reduce pain. Administered orally, Gabakan may be taken with or without food, ideally before sleep, at the same time daily for consistent blood levels. Dosage and duration should follow your physician's instructions. Missed doses should be taken immediately upon recall. Complete the prescribed course, even with symptom improvement. Sudden cessation requires prior consultation with your doctor. Common side effects include nausea, peripheral swelling, unsteady gait, blurred vision, fever, and involuntary eye movement (nystagmus). Dizziness and drowsiness may occur; avoid driving or mentally demanding tasks until effects are known. Report any unusual mood or behavioral changes, new or worsening depression, or suicidal ideation to your doctor. Disclose pregnancy, pregnancy plans, or breastfeeding before starting treatment. While generally compatible with other medications, interactions exist with certain drugs (including antacids and alcohol), potentially increasing adverse effects.
Uses of Gabakan 300mg/500mcg Tablet
Managing neuropathic pain
Major Benefits of Gabakan 300mg/500mcg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gabakan 300mg/500mcg tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Gabakan 300mg/500mcg Tablet:
- Dizziness
- Sleepiness
- Tiredness
- Uncoordinated body movements
How to use Gabakan 300mg/500mcg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Gabakan 300mg/500mcg tablets can be consumed with or without food, though consistent timing is recommended.
How Gabakan 300mg/500mcg Tablet works:
Gabapentin 300mg/500mcg tablets combine gabapentin and methylcobalamin to alleviate neuropathic pain. Gabapentin, an alpha-2-delta ligand, reduces pain signals by influencing nerve cell calcium channels. Methylcobalamin, a vitamin B12 derivative, supports myelin production, protecting and repairing nerve fibers. This dual action targets the underlying causes of nerve-related pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Gabakan 300mg/500mcg tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Gabakan 300mg/500mcg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Using Gabakan 300mg/500mcg tablets while breastfeeding appears to be safe. Available human data indicates minimal risk to the infant. However, close observation of the baby for drowsiness and increased weight is recommended.
DrivingUNSAFE
Taking Gabakan 300mg/500mcg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Gabakan 300mg/500mcg tablets cautiously. Dosage modification may be necessary for these patients. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data on Gabakan 300mg/500mcg Tablet use in individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Gabakan 300mg/500mcg Tablet :
Should you forget a Gabakan 300mg/500mcg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gabakan 300mg/500mcg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
